Related references
Note: Only part of the references are listed.Transition to invasive breast cancer is associated with progressive changes in the structure and composition of tumor stroma
Tyler Risom et al.
CELL (2022)
The breast pre-cancer atlas illustrates the molecular and microenvironmental diversity of ductal carcinoma in situ
Daniela Nachmanson et al.
NPJ BREAST CANCER (2022)
The harsh microenvironment in early breast cancer selects for a Warburg phenotype
Mehdi Damaghi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)
SCDC: bulk gene expression deconvolution by multiple single-cell RNA sequencing references
Meichen Dong et al.
BRIEFINGS IN BIOINFORMATICS (2021)
Contrasting DCIS and invasive breast cancer by subtype suggests basal-like DCIS as distinct lesions
Helga Bergholtz et al.
NPJ BREAST CANCER (2020)
BCL9/STAT3 regulation of transcriptional enhancer networks promote DCIS progression
Hanan S. Elsarraj et al.
NPJ BREAST CANCER (2020)
Upregulation of HIF1-α via an NF-κB/COX2 pathway confers proliferative dominance of HER2-negative ductal carcinoma in situ cells in response to inflammatory stimuli
Dominika Piasecka et al.
NEOPLASIA (2020)
Immune microenvironment in ductal carcinoma in situ: a comparison with invasive carcinoma of the breast
Milim Kim et al.
BREAST CANCER RESEARCH (2020)
Twenty-Five Year Trends in the Incidence of Ductal Carcinoma in Situ in US Women
Tawakalitu O. Oseni et al.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2019)
Impact of Epithelial-Stromal Interactions on Peritumoral Fibroblasts in Ductal Carcinoma in Situ
Carina Strell et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2019)
The COMET (Comparison of Operative versus Monitoring and Endocrine Therapy) trial: a phase III randomised controlled clinical trial for low-risk ductal carcinoma in situ (DCIS)
E. Shelley Hwang et al.
BMJ OPEN (2019)
Ductal carcinoma in situ: to treat or not to treat, that is the question
Maartje van Seijen et al.
BRITISH JOURNAL OF CANCER (2019)
Comprehensive Integration of Single-Cell Data
Tim Stuart et al.
CELL (2019)
An Integrative Model of Cellular States, Plasticity, and Genetics for Glioblastoma
Cyril Neftel et al.
CELL (2019)
IKAP-Identifying K mAjor cell Population groups in single-cell RNA-sequencing analysis
Yun-Ching Chen et al.
GIGASCIENCE (2019)
Cross-talk between SIM2s and NFκB regulates cyclooxygenase 2 expression in breast cancer
Garhett L. Wyatt et al.
BREAST CANCER RESEARCH (2019)
Transcriptome evolution from breast epithelial cells to basal-like tumors
Gabriel Santpere et al.
ONCOTARGET (2018)
Multiclonal Invasion in Breast Tumors Identified by Topographic Single Cell Sequencing
Anna K. Casasent et al.
CELL (2018)
Progression-specific genes identified in microdissected formalin-fixed and paraffin-embedded tissue containing matched ductal carcinoma in situ and invasive ductal breast cancers
Silke Schultz et al.
BMC MEDICAL GENOMICS (2018)
Identification of Jun loss promotes resistance to histone deacetylase inhibitor entinostat through Myc signaling in luminal breast cancer
Maki Tanioka et al.
GENOME MEDICINE (2018)
SOX11 promotes invasive growth and ductal carcinoma in situ progression
Erik Oliemuller et al.
JOURNAL OF PATHOLOGY (2017)
Multigene Expression Assay and Benefit of Radiotherapy After Breast Conservation in Ductal Carcinoma in Situ
Eileen Rakovitch et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2017)
Salmon provides fast and bias-aware quantification of transcript expression
Rob Patro et al.
NATURE METHODS (2017)
Decoupling genetics, lineages, and microenvironment in IDH-mutant gliomas by single-cell RNA-seq
Andrew S. Venteicher et al.
SCIENCE (2017)
Immune Escape in Breast Cancer During In Situ to Invasive Carcinoma Transition
Carlos R. Gil Del Alcazar et al.
CANCER DISCOVERY (2017)
Multigene Expression Assay and Benefit of Radiotherapy After Breast Conservation in Ductal Carcinoma in Situ
Eileen Rakovitch et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2017)
NEMO, a Transcriptional Target of Estrogen and Progesterone, Is Linked to Tumor Suppressor PML in Breast Cancer
Hanan S. Elsarraj et al.
CANCER RESEARCH (2017)
p63/MT1-MMP axis is required for in situ to invasive transition in basal-like breast cancer
C. Lodillinsky et al.
ONCOGENE (2016)
Weight loss reduces basal-like breast cancer through kinome reprogramming
Yuanyuan Qin et al.
CANCER CELL INTERNATIONAL (2016)
The immune microenvironment of breast ductal carcinoma in situ
Elizabeth Thompson et al.
MODERN PATHOLOGY (2016)
Molecular Features of Subtype-Specific Progression from Ductal Carcinoma In Situ to Invasive Breast Cancer
Robert Lesurf et al.
CELL REPORTS (2016)
Aberrant activation of NF-κB signaling in mammary epithelium leads to abnormal growth and ductal carcinoma in situ
Whitney Barham et al.
BMC CANCER (2015)
Cross-species DNA copy number analyses identifies multiple 1q21-q23 subtype-specific driver genes for breast cancer
Grace O. Silva et al.
BREAST CANCER RESEARCH AND TREATMENT (2015)
A Cytoplasmic NF-κB Interacting Long Noncoding RNA Blocks IκB Phosphorylation and Suppresses Breast Cancer Metastasis
Bodu Liu et al.
CANCER CELL (2015)
A Molecular Portrait of High-Grade Ductal Carcinoma In Situ
Martin C. Abba et al.
CANCER RESEARCH (2015)
The LORIS Trial: Addressing Overtreatment of Ductal Carcinoma In Situ
A. Francis et al.
CLINICAL ONCOLOGY (2015)
Feasibility of a prospective, randomised, open-label, international multicentre, phase III, non-inferiority trial to assess the safety of active surveillance for low risk ductal carcinoma in situ - The LORD study
Lotte E. Elshof et al.
EUROPEAN JOURNAL OF CANCER (2015)
Rethinking the Standard for Ductal Carcinoma In Situ Treatment
Laura Esserman et al.
JAMA ONCOLOGY (2015)
Breast Cancer Mortality After a Diagnosis of Ductal Carcinoma In Situ
Steven A. Narod et al.
JAMA ONCOLOGY (2015)
Continued observation of the natural history of low-grade ductal carcinoma in situ reaffirms proclivity for local recurrence even after more than 30 years of follow-up
Melinda E. Sanders et al.
MODERN PATHOLOGY (2015)
PD-L1 Expression in Triple-Negative Breast Cancer
Elizabeth A. Mittendorf et al.
CANCER IMMUNOLOGY RESEARCH (2014)
STAR: ultrafast universal RNA-seq aligner
Alexander Dobin et al.
BIOINFORMATICS (2013)
GSVA: gene set variation analysis for microarray and RNA-Seq data
Sonja Haenzelmann et al.
BMC BIOINFORMATICS (2013)
A Multigene Expression Assay to Predict Local Recurrence Risk for Ductal Carcinoma In Situ of the Breast
Lawrence J. Solin et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2013)
Transcriptomic classification of genetically engineered mouse models of breast cancer identifies human subtype counterparts
Adam D. Pfefferle et al.
GENOME BIOLOGY (2013)
Role of HGF in epithelial-stromal cell interactions during progression from benign breast disease to ductal carcinoma in situ
Patricia Casbas-Hernandez et al.
BREAST CANCER RESEARCH (2013)
Basal-like Breast cancer DNA copy number losses identify genes involved in genomic instability, response to therapy, and patient survival
Victor J. Weigman et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Molecular signatures database (MSigDB) 3.0
Arthur Liberzon et al.
BIOINFORMATICS (2011)
Building prognostic models for breast cancer patients using clinical variables and hundreds of gene expression signatures
Cheng Fan et al.
BMC MEDICAL GENOMICS (2011)
Human primary ductal carcinoma in situ (DCIS) subtype-specific pathology is preserved in a mouse intraductal (MIND) xenograft model
Kelli Elizabeth Valdez et al.
JOURNAL OF PATHOLOGY (2011)
Trends in incidence of ductal carcinoma in situ: The effect of a population-based screening programme
Ragnhild Sorum et al.
BREAST (2010)
Molecular diversity in ductal carcinoma in situ (DCIS) and early invasive breast cancer
Aslaug Aamodt Muggerud et al.
MOLECULAR ONCOLOGY (2010)
Supervised Risk Predictor of Breast Cancer Based on Intrinsic Subtypes
Joel S. Parker et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
An intraductal human-in-mouse transplantation model mimics the subtypes of ductal carcinoma in situ
Fariba Behbod et al.
BREAST CANCER RESEARCH (2009)
Carcinoma-associated fibroblast-like differentiation of human mesenchymal stem cells
Pravin J. Mishra et al.
CANCER RESEARCH (2008)
Molecular Grading of Ductal Carcinoma In situ of the Breast
Rosemary L. Balleine et al.
CLINICAL CANCER RESEARCH (2008)
Ductal carcinoma in situ and the emergence of diversity during breast cancer evolution
D. Craig Allred et al.
CLINICAL CANCER RESEARCH (2008)
Cellular adaptations to hypoxia and acidosis during somatic evolution of breast cancer
R. A. Gatenby et al.
BRITISH JOURNAL OF CANCER (2007)
Identification of a basal-like subtype of breast ductal carcinoma in situ
Chad A. Livasy et al.
HUMAN PATHOLOGY (2007)
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
A Subramanian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
The natural history of low-grade ductal carcinoma in situ of the breast in women treated by biopsy only revealed over 30 years of long-term follow-up
ME Sanders et al.
CANCER (2005)
Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications
T Sorlie et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Molecular portraits of human breast tumours
CM Perou et al.
NATURE (2000)
The mammary pathology of genetically engineered mice: the consensus report and recommendations from the Annapolis meeting
RD Cardiff et al.
ONCOGENE (2000)
The C3(1)/SV40 T-antigen transgenic mouse model of mammary cancer: ductal epithelial cell targeting with multistage progression to carcinoma
JE Green et al.
ONCOGENE (2000)
Share Paper
